✦ LIBER ✦

Biological surrogate end-points in cancer trials: Potential uses, benefits and pitfalls

✍ Scribed by Rachel Cooper; Johannes H.A.M. Kaanders

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biological Surrogate End-Points in Cance

✍ Cooper, R.; Kaanders, J.H. 📂 Article 📅 2006 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 31 KB

Clinical End Points and Relevant Clinica

✍ García, Margarita; Navarro, Valentín; Clopés, Ana 📂 Article 📅 2014 🏛 Current Science Inc. 🌐 English ⚖ 224 KB

Clinical Trial Design in Small Cell Lung

✍ Nickolich, Myles; Babakoohi, Shahab; Fu, Pingfu; Dowlati, Afshin 📂 Article 📅 2014 🏛 CIG Media Group, LP. 🌐 English ⚖ 278 KB

The validation of surrogate end points b

✍ Tomasz Burzykowski; Geert Molenberghs; Marc Buyse 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB